Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Joo Young Ha"'
Publikováno v:
Diagnostics, Vol 14, Iss 14, p 1502 (2024)
The primary hepatic leiomyosarcoma is a rare malignant tumor arising from the smooth muscle cells in the hepatic vessels, bile ducts, and ligamentum teres. It is considered a subtype of hepatic sarcomas. We report awkward 18F-FDG PET-CT findings of a
Externí odkaz:
https://doaj.org/article/91ef9dae69fc4a33adaf52b345cbb748
Autor:
Joo Young Ha, Hyungwoo Cho, Heungsup Sung, Ah Ra Jung, Yoon Sei Lee, Sang-Wook Lee, Jin-Sook Ryu, Eun Jin Chae, Kyung Won Kim, Jooryung Huh, Chan-Sik Park, Dong-Joon Kim, Seon-Ok Kim, Dok Hyun Yoon
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundExtranodal natural killer T cell lymphoma (ENKTL) is a rare subtype of non-Hodgkin lymphoma with invariable infection of lymphoma cells with Epstein-Barr virus (EBV), and the presence of EBV-DNA in the blood is a well-known prognosticator.
Externí odkaz:
https://doaj.org/article/15fb193acf774f75b5f8a39ee47ef082
Autor:
Young-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, Dong-Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae-Won Lee, Joohyuk Sohn, So Yeon Oh, Kyung Hee Lee, Su-Jin Koh, Keun Seok Lee, Chan-Kyu Kim, Ji-Yeon Kim, Jun Ho Ji, Sung-Bae Kim, Joo Young Ha, Ho Young Kim
Publikováno v:
Cancer Research and Treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e429d6e3c0bfb78037e64c77f5251fa9
https://doi.org/10.4143/crt.2022.1565
https://doi.org/10.4143/crt.2022.1565
Autor:
Ju Won Kim, Hee Kyung Ahn, Jong Gwon Choi, Yee Soo Chae, Gyeong-Won Lee, Keon Uk Park, Eunmi Lee, Sung Hoon Sim, Jee Hyun Kim, Yeon Hee Park, Miso Kim, Jin Hyun Park, Jeong Eun Kim, Han Jo Kim, Mi Sun Ahn, So Yeon Oh, Min Hwan Kim, Su-Jin Koh, Kyoung Eun Lee, Myoung Joo Kang, Jae Ho Byun, Joo Young Ha, Jung Hye Kwon, Joo Young Jung, Su Ee Lee, Inhae Park, Kyong Hwa Park
Publikováno v:
Cancer Research. 82:P5-16
Background: Prognosis of patients with HER-2 positive metastatic breast cancer (MBC) has been revolutionized with the development of monoclonal antibodies targeting HER-2 and antibody-drug conjugate, but resistance to anti-HER-2 therapy is inevitable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a63d2822ddcf7c20e34c35f4feac14ea
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-03
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-03
Autor:
Song Ee Park, Du Hwan Kim, Don-Kyu Kim, Joo Young Ha, Joung-Soon Jang, Jin Hwa Choi, In Gyu Hwang
Purpose Sarcopenia is a poor prognostic factor in cancer patients, and exercise is one of the treatments to improve sarcopenia. However, there is currently insufficient evidence on whether exercise can improve sarcopenia in patients with advanced can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69038d9916da166781837ab9a80e656a
https://doi.org/10.21203/rs.3.rs-2351843/v1
https://doi.org/10.21203/rs.3.rs-2351843/v1
Autor:
Myoung Joo Kang, Joo Young Jung, Jung Hye Kwon, Sung Hoon Sim, Keon Uk Park, Hee Kyung Ahn, Jeong Eun Kim, Ju Won Kim, So Yeon Oh, Joo Young Ha, Mi Sun Ahn, Su Ee Lee, Min Hwan Kim, Kyong Hwa Park, Han Jo Kim, Eun Mi Lee, Su-Jin Koh, Kyoung Eun Lee, In Hae Park, Jin Hyun Park, Jong Gwon Choi, Yeon Hee Park, Yee Soo Chae, Miso Kim, Jae Ho Byun, Gyeong Won Lee, Jee Hyun Kim
Publikováno v:
Cancer Research. 81:PS11-39
Background: Prognosis of patients with HER-2 positive metastatic breast cancer (MBC) has been revolutionized with the development of dual antibodies targeting HER-2 and antibody-drug conjugate, but resistance to anti-HER-2 therapy is inevitable ultim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32ea56aca5ce164ea9f5df1c0d67f552
https://doi.org/10.1158/1538-7445.sabcs20-ps11-39
https://doi.org/10.1158/1538-7445.sabcs20-ps11-39
Autor:
Jooryung Huh, Ah Ra Jung, Kyoungmin Lee, Dok Hyun Yoon, Eun Jin Chae, Cheolwon Suh, Sang-wook Lee, Jin-Sook Ryu, Kyung Won Kim, Yoon Sei Lee, Chan-Sik Park, Joo Young Ha
Publikováno v:
Leukemia & Lymphoma. 61:1575-1583
We evaluated real-world effectiveness and safety of CT-P10 (Truxima®) compared with originator rituximab in diffuse large B-cell lymphoma (DLBCL) treatment. Before and after the introduction of CT-...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e532660f883e64ce42dbcaa4d1ab2b9d
https://doi.org/10.1080/10428194.2020.1742906
https://doi.org/10.1080/10428194.2020.1742906
Publikováno v:
Processes; Aug2022, Vol. 10 Issue 8, p1580-1580, 9p
Autor:
Hyungwoo Cho, Jin-Sook Ryu, Yoon Sei Lee, Seon-Ok Kim, Dok Hyun Yoon, Sang-wook Lee, Ah Ra Jung, Heungsup Sung, Jooryung Huh, Joo Young Ha, Eun Jin Chae, Dong-Joon Kim, Kyung Won Kim, Chan-Sik Park
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
BackgroundExtranodal natural killer T cell lymphoma (ENKTL) is a rare subtype of non-Hodgkin lymphoma with invariable infection of lymphoma cells with Epstein-Barr virus (EBV), and the presence of EBV-DNA in the blood is a well-known prognosticator.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ce0584115e7153a963adbf6b0880e0
https://www.frontiersin.org/articles/10.3389/fonc.2020.594692/full
https://www.frontiersin.org/articles/10.3389/fonc.2020.594692/full
Autor:
Junyoung, Choi, Hee Jin, Lee, Shinkyo, Yoon, Hyun-Min, Ryu, Eunjin, Lee, Yujin, Jo, Seyoung, Seo, Deokhoon, Kim, Chang Hoon, Lee, Wanlim, Kim, Joo Young, Ha, Soo-Youl, Kim, Gyungyub, Gong, Kyung Hae, Jung, Sook Ryun, Park, Sang-We, Kim, Kang-Seo, Park, Dae Ho, Lee
Publikováno v:
Am J Cancer Res
Anti-PD-1/PD-L1 immunotherapy, as a treatment for many tumors, has shown good efficacy. However, responses to immunotherapy did not always occur or last long., i.e. primary or acquired resistance, even tumors were PD-L1 positive. Several oncogenic pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f8184600904b28e3968f4ff2624444d
https://pubmed.ncbi.nlm.nih.gov/33042623
https://pubmed.ncbi.nlm.nih.gov/33042623